The Racing Medication and Testing Consortium believes the majority of racing jurisdictions will have a substantial portion of the National Uniform Medication Program in place by year's end.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
The United States District Court in the Northern District of New York has dismissed a wrongful-death lawsuit filed by a group of Thoroughbred owners against New Jersey-based Wedgewood Pharmacy in September 2005.
The American Association of Equine Practitioners, in an effort to educate members, has issued guidelines for the responsible use of compounded medications by veterinarians.
Most Popular Stories
- Shared Belief Sprints to Game Malibu Triumph
- Sam's Sister Stuns Taris in Quick La Brea
- Alert Bay Wins Mathis Brothers Mile Thriller
- California Chrome is Vox Populi Award Winner
- Prado 'Day to Day' After Gulfstream Spill
- Spotted Heart Upsets MD Filly Championship
- New York Stallion Series On Tap at Aqueduct
- Leave the Light On for Storm Cat
- Nine-Month Suspension Recommended for Veitch
- Salutos Amigos Adds Gravesend Stakes Victory